Pott's puffy tumor in a premature neonate: the new youngest case reported in the post-antibiotic era

Orbit
Sean Cheng, Phung Vu

Abstract

An extreme premature infant born at 25 weeks post menstrual age (PMA) presented at PMA of 32 weeks with non-multiresistant methicillin resistant Staphylococcus aureus (MRSA) Pott's puffy tumor (PPT) involving both orbital and intracranial extension is described here. This is the youngest case of PPT ever reported in the antibiotic era.

References

Sep 11, 2001·Pediatric Neurosurgery·N C Bambakidis, A R Cohen
Dec 6, 2001·Ophthalmology·A A CruzJ Elia
Jan 20, 2004·Journal of AAPOS : the Official Publication of the American Association for Pediatric Ophthalmology and Strabismus·Dorothy J ReynoldsI Rand Rodgers
May 8, 2004·International Journal of Pediatric Otorhinolaryngology·Michael GuptaVivek Mehta
Apr 7, 2007·Ophthalmic Plastic and Reconstructive Surgery·Brent R HayekAmjad Z Ahmad
Dec 25, 2007·Journal of AAPOS : the Official Publication of the American Association for Pediatric Ophthalmology and Strabismus·David F Vazan, Sylvia R Kodsi
Nov 26, 2008·The American Journal of Medicine·Sarah E Forgie, Thomas J Marrie
Dec 9, 2008·Journal of Cranio-maxillo-facial Surgery : Official Publication of the European Association for Cranio-Maxillo-Facial Surgery·Eleftherios VairaktarisMichael N Moschos

❮ Previous
Next ❯

Citations

Apr 9, 2010·Child's Nervous System : ChNS : Official Journal of the International Society for Pediatric Neurosurgery·Taopheeq Bamidele Rabiu
Jun 18, 2011·The Pediatric Infectious Disease Journal·Vikram L VaskaMichael D Nissen
Jul 6, 2014·Child's Nervous System : ChNS : Official Journal of the International Society for Pediatric Neurosurgery·J Francisco SalomãoBernardo de A Pereira
Dec 9, 2014·Pediatric Annals·Harbir Singh Arora, Nahed Abdel-Haq
Apr 11, 2012·American Journal of Rhinology & Allergy·Lluís NisaRoland Giger
Dec 21, 2018·The Laryngoscope·Petros KoltsidopoulosCharalampos Skoulakis

❮ Previous
Next ❯

Related Concepts

Related Feeds

CRISPR & Staphylococcus

CRISPR-Cas system enables the editing of genes to create or correct mutations. Staphylococci are associated with life-threatening infections in hospitals, as well as the community. Here is the latest research on how CRISPR-Cas system can be used for treatment of Staphylococcal infections.